TOWER SEMICONDUCTOR LTD. (TSEM): what the price assumes

Generated: 2026-08-01 · Exported: 2026-08-03 · Source: https://boothcheck.com/report/TSEM

Headline

Field	Value
Ticker	TSEM
Company	TOWER SEMICONDUCTOR LTD.
Sector / Industry	Technology / Semiconductors
Current price	$185.32/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Must persist for	21.6y
Multiple paid	106x operating income

Solve inputs: computed at a 11.6% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.9 years.

Reconcile: at the x-ray's 9.3% required return this reads ~15.4 years; the models below use their own rates.

How unusual the bet is: elevated

Reference	Value
vs own history	+0.30σ
sustained it ~10 years at this level	15%
implied end-window share	0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	9.84x	5	expensive
Earnings	7.26x	3	expensive
Relative	2.63x	5	expensive
Growth	3.27x	2	expensive

Families that call it expensive: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=15)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$45.70	4.06x	yes	Reference only (OCF-based, capex excluded): OCF $0.4B
DCF Exit Multiple	Growth	$0.00	—	no	Negative/zero FCF or EBITDA — equity value floored at $0
Relative Valuation	Relative	$95.89	1.93x	yes	P/E 44.05x (blended: static sector reference 22x + trailing (TTM) 95x), scenarios: 36.8x / 44.0x / 51.3x (bear / base = reference held flat / bull), EV/EBITDA 23.87x
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$20.98	8.83x	yes	BV/sh $25.83, ROE (TTM) 7.5%, ke 9.3%
Two-Stage Excess Return	Asset	$18.84	9.84x	yes	5yr excess ROE then converge to ke=9.3%
Discounted Future Market Cap	Growth	$74.88	2.47x	yes	Rev $1.6B, growth 2% (input: historical growth; tapered), Terminal P/S: 6.7x / 8.0x / 9.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair Value	Relative	$55.29	3.35x	yes	EPS $1.94, growth 28% (input: historical EPS growth), PEG=3.35 (Overvalued)
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$25.54	7.26x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $0.29B × (1−9%) / WACC 9.2% → EPV (no growth)
Residual Income	Asset	$18.52	10.01x	yes	BV $25.83 + 5yr PV of (ROE (TTM) 7.5% − Kₑ 9.3%) × BV; BV grows 4.9%/yr
Graham Number	Asset	$33.58	5.52x	yes	√(22.5 × EPS $1.94 × BVPS $25.83) — Graham's conservative floor
EV/EBITDA Relative	Relative	$70.55	2.63x	yes	EBITDA $0.50B × sector EV/EBITDA 16.0x
FCF Yield	Earnings	—	—	no	—
SBC-Adj FCF Yield	Earnings	—	—	no	—
Ben Graham Formula	Earnings	$62.60	2.96x	yes	EPS $1.94 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/B	Asset	$17.27	10.73x	yes	BV $25.83 × (ROIC 6.1% / WACC 9.2%)
P/Sales Sector	Relative	$68.93	2.69x	yes	Revenue $1.57B × sector P/S 5.0x
PEG Fair Value	Relative	$72.75	2.55x	yes	EPS $1.94 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x
Earnings Yield	Earnings	$20.97	8.84x	yes	EPS $1.94 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net cash	$965.3m
Net debt / NOPAT (after-tax)	-5.46x (net cash)
Net debt / operating income (pre-tax)	-4.97x (net cash)
Interest coverage	53.1x
Share count CAGR (dilution)	0.9%
Burning cash	no

Bullet Takeaways

• Tower Semiconductor is a specialty analog foundry that has become an AI-infrastructure supplier: silicon photonics revenue tripled year over year in the March quarter, and customers have signed $1.3 billion of silicon photonics contracts for 2027 delivery.
• The defining risk is the price itself: at roughly 115 times trailing earnings against a semiconductor sector median of 22, no standard valuation approach reaches today's level, and the growth embedded in it would need to persist for decades rather than years.
• Watch the record second-quarter guide of $455 million in revenue, plus or minus 5 percent, and whether the $920 million capacity program completes qualification in the fourth quarter of 2026 on schedule.

Bull Case

The market is pricing Tower as the picks-and-shovels supplier of AI's optical layer, and the fundamentals have started confirming the thesis on schedule. Every AI data center needs optical interconnect, optical interconnect needs photonic integrated circuits, and Tower's silicon photonics platform is one of the few open-foundry sources for them: SiPho revenue tripled year over year in the first quarter, silicon germanium rose 24 percent, RF SOI 12 percent, and the whole company grew revenue 15 percent to $414 million while gross profit jumped 52 percent and operating profit 96 percent. That last pair is the important one. A foundry's economics hinge on utilization, and profits growing six times faster than revenue is what it looks like when a fab fills up.

The demand is contracted, not forecast. Customers have paid $290 million in prepayments to reserve capacity, an unusual arrangement in which the buyers are financing the seller's expansion, and management stated the actual 2027 silicon photonics forecast runs substantially higher than the contracted floor. The ecosystem is thickening around the platform: Tower has shipped more than five million coherent photonic integrated circuits through its Marvell partnership for data center interconnect, and the June 15, 2026 agreement with IQE locks in multi-year indium phosphide epiwafer supply, supporting 200-gigabit-per-lane transceivers and development of 400-gigabit modulators, while settling all outstanding IP litigation between the two.

The expansion is funded from a position of unusual strength. The $920 million silicon photonics and silicon germanium investment program, about 40 percent already paid, targets full qualification by the fourth quarter of 2026 and full production starts in 2027, and it sits on a net-cash balance sheet with a current ratio of 6.5 and debt at six percent of equity. There is no leverage clock and no financing dependency between here and the payoff. Management's 2028 model calls for $2.8 billion of annual revenue and $750 million of net profit, roughly a doubling of revenue from the trailing $1.57 billion, and the sequence toward it, record guidance of sequential revenue and margin growth through 2026, is being marked to market one quarter at a time.

Bear Case

Follow the cash before the story. Tower generated $400 million of operating cash flow over the trailing year and spent essentially all of it and more, leaving free cash flow negative, while committing to a $920 million equipment program with roughly 60 percent still to be paid through 2027. There is no dividend, no buyback, and the share count is rising, so every dollar the business produces, plus some dilution, is being converted into cleanroom capacity for a demand forecast centered on one end market: AI data center interconnect. The customer prepayments funding part of the build are double-edged; capacity reserved by your largest customers is also capacity pre-committed at negotiated terms, and the $1.3 billion of 2027 contracts concentrates the payoff in a handful of counterparties. If AI capex digests, and hyperscaler spending has never moved in straight lines, shareholders own the fixed costs.

The industry Tower operates in says this risk is not hypothetical. Fellow foundry UMC's own filing describes a business that has "historically been highly cyclical and, at various times, has experienced significant downturns" (accession 0001193125-26-193757), and smaller specialty peer SkyWater warns of rivals with "longer operating histories, greater name recognition, access to larger customer bases, and significantly greater financial, sales and marketing, manufacturing" resources (accession 0001819974-26-000009). The cautionary giant is in the peer data: Intel's foundry investment cycle produced a 34.8 percent gross margin and a negative operating margin on $52.9 billion of revenue in its latest fiscal year. Building capacity ahead of demand is how foundries win, and also how they get hurt; the difference is only visible after the capex is spent.

Now the price. At about 118 times trailing operating income, today's valuation implies operating growth held at the fastest internally fundable pace for roughly 24 years; among comparable fast-growers, only about 15 percent sustained such growth for even ten. Every valuation family reads the stock as rich, including the forward-growth methods that give full credit to the ramp. Even taking management's 2028 target at face value, the current $25.3 billion market value is already about 34 times the $750 million net profit the company hopes to earn two years from now. That leaves the stock no room for an ordinary semiconductor inventory cycle, a slipped qualification date, or a single large customer rescheduling its optics roadmap. The bull needs everything on the announced schedule; the bear only needs the industry to behave the way UMC's filing says it always eventually does.

Valuation

Today's price is paying for a very long future. At $222.92 (July 2026), the market pays about 118 times trailing operating income, which unwinds into an assumption that company-wide operating profit compounds at its self-funding ceiling for roughly 24 years. The near-term pace is not the stretch; Tower is currently delivering growth consistent with the required rate, and second-quarter guidance of $455 million would mark a company record at 22 percent year-over-year growth. The stretch is duration: among comparable fast-growers, only about 15 percent sustained this kind of pace for even ten years, and the price asks for more than twice that.

The method families are unanimous in a way they rarely are. Asset-based approaches land at a small fraction of the price, earnings-power methods likewise, peer multiples read the stock at roughly three times what the sector's own multiples would carry, and even forward-growth methods that credit the ramp sit well below today's level. The trailing multiples state the same thing without modeling: 115 times earnings against a sector median of 22, about 51 times EBITDA against 16, and 16 times sales. When no family reaches the price, the market is not disagreeing with one lens; it is paying for something outside all of them, here the conversion of a $1.57 billion specialty foundry into a multiple of itself as AI optical demand scales through 2027 and beyond.

The balance sheet is the calm part of the picture. Tower holds net cash with a current ratio of 6.5, so the negative free cash flow of the build years, with about 60 percent of the equipment program still to pay through 2027, creates no solvency pressure, and $290 million of customer prepayments offsets part of the outlay. What has to be true at this price is a chain: sequential revenue and margin growth through 2026 as guided, full capacity qualification in the fourth quarter, conversion of the 2027 contract book, and then, the demanding part, continued compounding for many years after the currently visible contracts end. The first links are trackable quarter by quarter; the last one is the bet.

Catalysts

The first-quarter report on May 13, 2026 reset the trajectory: revenue of $414 million, up 15 percent year over year, gross profit up 52 percent to $111 million, operating profit up 96 percent to $65 million, and record second-quarter guidance of $455 million, plus or minus 5 percent, implying 22 percent year-over-year and 10 percent sequential growth. Management is targeting sequential revenue and margin growth every quarter of 2026, so each upcoming print is a checkpoint against that explicit slope. Alongside the results came the demand disclosure that anchors the story: $1.3 billion of silicon photonics contracts for 2027 revenue signed with the company's largest customers, plus $290 million in customer prepayments for capacity reservation, with management noting the full 2027 photonics forecast runs substantially higher than the contracted amount.

June brought supply-chain and legal clean-up in one stroke: on June 15, Tower and IQE announced a multi-year indium phosphide epiwafer supply agreement supporting 200-gigabit-per-lane transceivers and 400-gigabit modulator development, and settled all outstanding IP disputes, with Tower granting IQE a royalty-free license to its porous silicon patents. The Marvell partnership continues to scale, with more than five million coherent photonic integrated circuits shipped for AI data center interconnect.

The operational calendar through year-end is unusually concrete: the $650 million capex plan plus $270 million of photonics equipment, $920 million in total, targets installation and full qualification in the fourth quarter of 2026, enabling full production starts at the beginning of 2027. Watch for qualification confirmation in the Q3 and Q4 reports, further 2027 contract additions or prepayments, and any hyperscaler capex commentary that moves the AI interconnect demand curve the whole thesis rides on.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• GFS (GLOBALFOUNDRIES Inc.)
• (no filing in the citation store)
• UMC (United Microelectronics Corporation)
• (no filing in the citation store)
• SKYT (SkyWater Technology, Inc.)
• (no filing in the citation store)
• AMKR (AMKOR TECHNOLOGY, INC.)
• (no filing in the citation store)
• VSH (VISHAY INTERTECHNOLOGY INC)
• (no filing in the citation store)
• TXN (TEXAS INSTRUMENTS INCORPORATED)
• (no filing in the citation store)
• ON (ON Semiconductor Corporation)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q1 2026 earnings release, May 13, 2026 · Q1 2026 earnings release · Q1 2026 earnings call via BigGo Finance · company announcement via TipRanks · Q1 2026 earnings call · TipRanks; company 6-K · company announcement